Content of circulating tumor DNA depends on the tumor type and the dynamics of tumor size, but is not influenced significantly by physical exercise, time of the day or recent meal-Reference-Cited by-同舟云学术

Content of circulating tumor DNA depends on the tumor type and the dynamics of tumor size, but is not influenced significantly by physical exercise, time of the day or recent meal

Published:2021-08 Issue: Volume:256-257 Page:165-178
ISSN:2210-7762
Container-title:Cancer Genetics
language:en
Short-container-title:Cancer Genetics

Author:

Kuligina Ekaterina S.^ORCID,Meerovich Roman,Zagorodnev Kirill A.^ORCID,Kholmatov Maxim M.,Sokolova Tatyana N.,Laidus Tatiana A.,Romanko Aleksandr A.,Martianov Aleksandr S.^ORCID,Anisimova Maria O.^ORCID,Zaitseva Olga A.,Yatsuk Olga S.,Yanus Grigoriy A.,Imyanitov Evgeny N.

Funder

Russian Science Foundation

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Molecular Biology

Reference53 articles.

1. Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin;Snyder;Cell,2016

2. Enhanced detection of circulating tumor DNA by fragment size analysis;Mouliere;Sci Transl Med,2018

3. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution;Abbosh;Nature,2017

4. Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling;Chaudhuri;Cancer Discov,2017

5. Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study);Garlan;Clin Cancer Res,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status of molecular diagnostics for lung cancer;Exploration of Targeted Anti-tumor Therapy;2024-06-27

2. Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1-Driven Breast Cancer Patients;International Journal of Molecular Sciences;2023-01-18

3. NPY Gene Methylation in Circulating Tumor DNA as an Early Biomarker for Treatment Effect in Metastatic Colorectal Cancer;Cancers;2022-09-14

4. Reporting on circulating tumor DNA monitoring in metastatic cancer—From clinical validity to clinical utility;Cancer;2022-03-18

5. Integration of the blood test into the low-dose computed tomography lung cancer screening: reliable discrimination between malignant and non-malignant radiographic findings;Translational Lung Cancer Research;2021-10